Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
The Opportunity The Senior Manager, Japan Insights & Analytics (I&A) plays a critical role in enabling data-driven decision-making across CSL Behring Japan by delivering strategic insights, advanced analytics, forecasting, and market intelligence that support commercial performance
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Join Clario, a part of Thermo Fisher Scientific and lead the delivery of innovative eCOA solutions that support neuroscience clinical trials around the world. As a Lead Project Manager, eCOA Neurosciences, you will provide both project
メルクと一緒に、あなたの力を発揮しよう！ 冒険、限界への挑戦、そして発見に焦がれるあなたへ。あなたの大志を、メルクで羽ばたかせましょう！科学とテクノロジーを駆使したイノベーションに情熱を注ぐメルクのスタッフは世界中で活躍中です。ヘルスケア、生命科学、エレクトロニクスの分野で、メルクのソリューションは人々の暮らしをますます豊かなものにしています。あなたとメルクの力を合わせて、大きな夢を抱きましょう。メルクは、人、顧客、患者、そしてこの地球という惑星が共存する豊かな世界の構築に情熱を注いでいます。このためメルクでは、好奇心にあふれた人材を募集中です。メルクと一緒に、想像を超えた世界を開拓しませんか？ This position reports to the Head of Excipients & Biopharma Chemicals - APeC. The candidate should have bachelor’s degree in Pharmaceuticals, Life Sciences, Biotechnology, Chemical Engineering or other relevant field with 5-7 years of experience.
At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Locations: Tokyo, Japan Categories: Clinical Safety Req ID: 13060 We are currently seeking a full-time, office-based Drug Safety Coordinator/Safety Specialist to join our Clinical Safety department in Tokyo, Japan. This position will be focused on the
Locations: Tokyo, Japan Categories: Clinical Trial Management Req ID: 12546 Medpace is the leading CRO for biotech companies and is continuing to add leaders to join our Clinical Trial Management team in Tokyo, Japan. Clinical Trial
Locations: Tokyo, Japan Categories: Clinical Trial Management Req ID: 12544 We are currently seeking a full-time, office-based Project Coordinator to join our Clinical Trial Management team in Tokyo, Japan. This position will work on a team
Locations: Tokyo, Japan Categories: Data Management Req ID: 12553 Our corporate activities are growing rapidly, and we are currently seeking a full-time, office-based Data Coordinator to join our Japan team in Tokyo. Globally, with greater emphasis
Locations: Tokyo, Japan Categories: Clinical Safety Req ID: 12663 Our corporate activities are growing rapidly, and we are currently seeking a full-time, office-based Administrative Assistant to join our Clinical Safety team in Tokyo, Japan. This position
Locations: Tokyo, Japan Categories: Clinical Safety Req ID: 12606 Our clinical operations activities are growing rapidly, and we are currently seeking a full-time, Associate Director, Clinical Safety to join our Clinical Safety Department in Tokyo, Japan.